The content is available as a PDF (78.3 KB).
Bibliografía
- 1.Wood D., De Backer G., Faegerman O., Graham I., Mancia G., Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force and other Societies on Coronary Prevention. Eur Heart J. 1998;19:1434–1503. [Google Scholar]
- 2.Wood D.A. for the EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357:995–1001. doi: 10.1016/s0140-6736(00)04235-5. [DOI] [PubMed] [Google Scholar]
- 3.Brotons C., Permanyer G., Pacheco V., Moral I., Ribera A., Cascant P. PREMISE Study Group. Prophylactic treatment after myocardial infarction in primary care: how far can we go? Fam Pract. 2003;20:32–35. doi: 10.1093/fampra/20.1.32. [DOI] [PubMed] [Google Scholar]
- 4.Llisterri J.L., Rodríguez Roca G., Alonso F.J., Lou S., Divisón J., Santos J.A. Control de la presión arterial en la población hipertensa española atendida en atención primaria. Estudio PRESCAP 2002. Med Clin (Barc. 2004;122:165–171. doi: 10.1016/s0025-7753(04)74183-4. [DOI] [PubMed] [Google Scholar]
- 5.Esmatjes E.C., Castell C., Franch J., Puigoriol E., Hernáez R. Consumo de ácido acetilsalicílico en pacientes con diabetes mellitus. Med Clin (Barc. 2004;122:96–98. doi: 10.1016/s0025-7753(04)74155-x. [DOI] [PubMed] [Google Scholar]
- 6.De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Executive summary. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601–1610. doi: 10.1016/s0195-668x(03)00347-6. [DOI] [PubMed] [Google Scholar]